Clinical Trials Directory

Trials / Completed

CompletedNCT02525549

Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
903 (actual)
Sponsor
Padagis LLC · Industry
Sex
All
Age
12 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the safety and bioequivalence of Perrigo's product to an FDA approved product for the treatment acne vulgaris.

Conditions

Interventions

TypeNameDescription
DRUGAdapalene and Benzoyl Peroxide Gel
DRUGAdapalene and Benzoyl Peroxide Gel (Reference)
DRUGPlacebo gel

Timeline

Start date
2011-12-01
Primary completion
2012-08-01
Completion
2012-08-01
First posted
2015-08-17
Last updated
2021-11-02
Results posted
2021-01-20

Source: ClinicalTrials.gov record NCT02525549. Inclusion in this directory is not an endorsement.